AN43--Intent to Sole Source Vaccine Research Services
Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24E23Q0099
- Agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 611310 Colleges, Universities, and Professional Schools
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs published a Special Notice of its intent to sole source a contract with the University of Wisconsin-Madison. The notice was issued by the Veterans Health Administration Veterans Integrated Service Network 4 on behalf of the James J. Peters VA Medical Center.
The Special Notice is to procure vaccine research services in support of an HIV vaccine study being conducted by investigators at the James J. Peters VA Medical Center. The services required are the production of specific DNA and protein under cGMP standards to enable proof of concept studies. The Waisman Center at the University of Wisconsin-Madison is the only known source able to meet these requirements based on its experience manufacturing cGMP vaccines for an HIV Vaccine Trials Network clinical trial. Interested parties may submit capability statements by March 27, 2023 detailing their ability to fulfill the requirements, and the contracting office will determine if competition is warranted based on any responses received to the Special Notice.
Notice text
The Department of Veterans Affairs, James J. Peters VA Medical Center (JJP VAMC) intends to negotiate on a sole source basis, pursuant to FAR 6.302-1, with the University of Wisconsin - Madison for vaccine research services. Investigators at the JJP VAMC are conducting HIV vaccine research. As part of this study, investigators require the production of DNA and protein in accordance with cGMP (current Good Manufacturing Practice) specifications in support of proof of concept studies. The Waisman Center at the University of Wisconsin Madison is the only known vendor able to produce the necessary specific DNA and specific protein under cGMP standards, and the Waisman Center has experience manufacturing cGMP-grade DNA and protein vaccines for a phase I clinical trial run by the HIV Vaccine Trials Network.
This is a notice of intent and is not a request for competitive quotes; however, any responsible source who can provide an equivalent service with the features described above may submit a capability statement to the contracting office no later than Monday, March 27, 2023, 11:00 AM EDT. Interest/capability statements which specifically detail how your service meets the requirement may be sent to Shannon Hukriede at shannon.hukriede@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.
Files
| File | Type | Posted |
|---|---|---|
| 36C24E23Q0099.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| AN43--Notice of Award Vaccine Research Services | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--leptomeningeal and coronary research services. | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity